Histiocytic disorders is a research paper published in Nature Reviews Disease Primers (2021). On theSindex it has a DataRank of 0.757. It has been cited 154 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.757
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Research UK
Grant: C30484/A21025
NCI NIH HHS
Grant: R01 CA233719
NICHD NIH HHS
Grant: R33 HD105593
NCI NIH HHS
Grant: P50 CA126752
NCI NIH HHS
Grant: R01 CA154947
Cancer Research UK
Grant: 21025
National Institutes of Health
Grant: 5R01CA154947-03
Characterizing a New Human Dendritic Cell Lineage and Its Role in LCH
National Institutes of Health
Grant: 5P50CA126752-14
SPORE in Lymphoma
FWCI
10.04
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing
Additional file 2 of Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing
Additional file 1 of Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing
Additional file 1 of Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing